Catalent investing $2.5m in new China-based clinical supply facility

By Melissa Fassbender contact

- Last updated on GMT

Catalent investing $2.5m in new China-based clinical supply facility

Related tags: Catalent pharma solutions, China, Supply chain

The new 30,000 square-foot facility is expected to employ 100 people and will double Catalent’s total clinical storage capacity in China.

Catalent Pharma Solutions provides delivery technologies and development solutions. The company this week announced plans to invest $2.5m in a new clinical supply facility in Shanghai, China.

The facility, which will be Catalent’s second in China, is due to open in early 2019 and will have three controlled temperature rooms operating at 2-8°C, 15-25°C, and -20°C.

It also will offer returns and destruction services, as well as its FastChain supply services, including GMP secondary packaging, final assembly, labeling, and distribution of clinical supplies.

"The facility's location, outside of Shanghai’s Free Trade Zone, helps Catalent’s customers by providing easier importation into China for trials in the country. In providing a more efficient, timely way of getting supplies to where customers want them, it minimizes transit time and risk of excursions of limited-shelf life products," ​a Catalent spokesperson told us. 

Catalent has an existing facility in Waigaoqiao, which opened in 2013 and provides Free Trade Zone (FTZ) access, among other services.

The spokesperson said, "more and more customers [are] doing global trials that include China, so having a pathway into China is important, as it helps Catalent provide China-based clients with our expertise in storage, distribution, packaging, and labeling."

Related news

Show more

Related products

show more

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Governing and Maintaining Clinical Data Standards

Governing and Maintaining Clinical Data Standards

Veeva | 10-May-2022 | Technical / White Paper

Investing in data standards plays a huge role in improving the quality of clinical studies. But often, people don’t use the standards correctly, there...

What the Best Clinical Study Build Pros Do

What the Best Clinical Study Build Pros Do

Formedix | 09-May-2022 | Technical / White Paper

Getting your clinical study designed and built ready for data collection takes A LOT of work and expertise… you've got to do all your CRF designs;...

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 18-Apr-2022 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Related suppliers

Follow us

Products

View more

Webinars